Omni Ophthalmic Management Consultants, a portfolio company of NMS Capital, has acquired Erie Retinal Surgery, a provider of medical-surgical retinal services in Western Pennsylvania. No financial terms were disclosed. Cross Keys Capital was financial advisor to Erie Retinal Surgery on the transaction.
Iselin, NJ and Erie, PA, April 8, 2021 – Omni Ophthalmic Management Consultants (“Omni”), a portfolio company of NMS Capital (“NMS”), announced today its strategic partnership with Erie Retinal Surgery (“Erie”), a market-leading regional provider of medical-surgical retinal services in Western Pennsylvania. Terms of the transaction were not disclosed.
Remarking on the transaction, Dr. Christopher Quinn, CEO of Omni, said, “Erie helps our platform expand further west in Pennsylvania, adding additional density in an existing state with two additional locations, including one injection suite, while also further diversifying our service mix through increased retina services. Erie’s reputation in the Pennsylvania market is unparalleled and we are excited to begin our partnership with Drs. Dailey, Baldwin, Babel and their team.”
Dr. J.P. Dailey, Erie Owner and Surgeon commented, “We are excited to partner with Omni and the opportunity it presents for our doctors and employees alike to continue building upon the strong foundation already in place. Erie has been providing high quality eye care in Western Pennsylvania for almost 40 years and we believe this partnership will help us continue providing excellent care to the patients in our community.”
Luis Gonzalez, Partner at NMS, added, “The Erie partnership, Omni’s seventh, allows the Company to continue its expansion west in Pennsylvania and further solidifies our presence as one of the largest ophthalmology groups in the Northeast and Mid-Atlantic with over 70 providers across nearly 30 practice locations, including several ambulatory surgery centers.”
Cross Keys Capital served as exclusive financial advisor to Erie Retinal Surgery on the transaction.
Omni is an optometric referral practice providing a full range of specialty services for the advanced treatment of eye diseases, based in Iselin, NJ. Omni, by design, offers no primary care optometric services, but promotes a partnership between optometry and ophthalmology to deliver exceptional vision care. Founded in 1998, Omni provides eye care services through a network of nearly 30 offices, including several that operate ophthalmology-focused ambulatory surgery centers, throughout New Jersey, New York, Pennsylvania, Delaware, and Maryland. With over 70 Board-certified ophthalmologists and residency-trained optometrists, supported by a staff of over 350 registered nurses, ophthalmic technicians, surgical technicians, and patient services representatives, Omni provides nearly 350,000 encounters annually.
For additional information on Omni, visit the company’s website at www.oomc.com
Headquartered in Erie, Pennsylvania, Erie Retinal Surgery is a market-leading medical-surgical retina services provider in Western Pennsylvania. For nearly 40 years, Erie has remained at the forefront of the eye care field and currently employs five Board-certified doctors. Through its two locations, including an injection suite, Erie offers comprehensive vision care services to approximately 40,000 patients annually. For additional information on Erie, visit the company’s website at https://www.erieretina.com/
NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The Firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services. For additional information on NMS, visit the firm’s website at www.nms-capital.com